Hikma Pharmaceutical | HIK - Cost Of Sales

Stock Price
1,408.00
Daily Change
9.50 0.68%
Monthly
7.65%
Yearly
-29.81%
Q2 Forecast
1,361.73

Hikma Pharmaceutical reported $959M in Cost of Sales for its fiscal semester ending in December of 2025.





Cost Of Sales Change Date
Almirall EUR 191.5M 2.29M Dec/2025
argenx SE USD 149.69M 40.26M Dec/2025
AstraZeneca USD -204M 3.48B Mar/2026
Autolus Therapeutics Ltd USD 25.33M 3.31M Dec/2025
Bayer EUR 4.5B 194M Dec/2025
Fresenius EUR 4.45B 262M Dec/2025
Galapagos EUR 455K 84.28M Dec/2025
Genmab DKK 81M 23M Dec/2025
GlaxoSmithKline GBP 1.88B 736M Mar/2026
GRIFOLS EUR 1.29B 163.12M Dec/2025
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Lonza CHF 2.28B 189M Jun/2025
Merck EUR 2.29B 183M Dec/2025
Orion EUR 163.7M 22.9M Mar/2026
Recordati EUR 199.91M 20.12M Sep/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 3.67B 621M Mar/2026
UCB EUR 1.07B 146M Dec/2025